Latest Illumina News & Updates

See the latest news and media coverage for Illumina. We track all announcements, press releases, and industry mentions in real time, all in one place.

Illumina

Genomic sequencing and array technology company

illumina.com

Headquarters: San Diego, United States
Founded year: 1998
Company type: Public company
Number of employees: 9,500–10,000
Industry: Biotechnology & Medical Research

Last updated Today

Latest news about Illumina

In short: Illumina reported strong 2026 financial results, raised its full-year guidance, and expanded its AI drug discovery and multiomic product portfolios.

Company announcements

July 30 Illumina

Illumina reported financial results for second quarter fiscal 2026

Revenue rose 9.5% to $1.16 billion, and the company raised its full-year guidance.

July 16 Illumina

Illumina expands Billion Cell Atlas program with new AI drug developers

The alliance includes Formation Bio and other AI-driven drug developers to advance precision medicines using genomic perturbation data.

July 9 Illumina

Illumina appoints Michael Sullivan CCO and Julie Coletti CLO

The new leaders bring experience in life sciences and diagnostics, effective July 20 and August 3, 2026.

July 9 Illumina

Illumina to announce second quarter 2026 financial results

The results will be released after market close on July 30, 2026, followed by a conference call with analysts.

Media coverage

August 2 Daily Political

Wall Street Zen Upgrades Illumina (NASDAQ:ILMN) to “Buy” - Daily Political

Illumina (NASDAQ:ILMN – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a...

August 2 The Globe and Mail

Analysts Have Conflicting Sentiments on These Healthcare Companies: Illumina (ILMN), Dyne Therapeutics (DYN) and Bristol-Myers Squibb (BMY)

According to TipRanks.com, Burstein is a 5-star analyst with an average return of 25.6% and a 76.7% success rate. Burstein covers the Healthcare sector, focusing...

July 30 Morningstar

Illumina Earnings: Strong Instrument Sales and Growing AI Opportunities Boost...

Morningstar is an investment research company offering mutual fund, ETF, and stock analysis, ratings, and data, and portfolio tools. Discover actionable insights today.

July 30 The Globe and Mail

Illumina (NASDAQ:ILMN) Surprises With Q2 CY2026 Sales, Full-Year Outlook Slightly Exceeds Expectations

Genomics company Illumina (NASDAQ:ILMN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. The...

Never miss news about Illumina

Track Illumina and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.